SENATE, No. 2039 - Diabetes and Stem Cell Research in Massachusetts

The Committee of Conference, to whom was referred the matters of difference between the two branches with reference to the House amendment to the Senate Bill promoting stem cell research (Senate, No. 2032) (amended by the House by striking out all after the enacting clause and inserting in place thereof the text contained in House document numbered 2792; by striking out the title and inserting in place thereof the following title: “An Act relative to biotechnology.”; and by striking out the emergency preamble and inserting in place thereof the following emergency preamble: “Whereas, The deferred operation of this act would tend to defeat its purpose, which is to forthwith regulate biotechnology in the Commonwealth, therefore it is hereby declared to be an emergency law, necessary for the immediate preservation of the public health and convenience, reports, a Bill Relative to Enhancing Regenerative Medicine in the Commonwealth (Senate, No. 2039).

Please visit the web site to view the article in its entirety.

The Commonwealth of Massachusetts
Mass.Gov Customer Support
Information Technology Division
200 Arlington Street
Chelsea, MA 02150
1-866-888-2808 (Toll-free Nationwide)
Mass.Gov@state.ma.us